Parkinson's Disease Trial, Recruiting (NCT07250672)

Parkinson's Disease Trial, Recruiting NCT07250672 Sponsor: Abant Izzet Baysal University Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07250672 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to take part in the study voluntarily
You have been diagnosed with Parkinson's disease by a neurologist
You are currently taking medication to treat your Parkinson's disease
Your Parkinson's symptoms are at a mild to moderate level (rated stage 3 or below on a standard scale used by doctors)
You are able to walk on your own without assistance

Who may not be able to join:

You have been diagnosed with another neurological condition in addition to Parkinson's disease
Your Parkinson's medication dose has been changed in the last month
You scored highly on a questionnaire that measures discomfort caused by simulators or virtual environments (confirm with trial site)
You have a lazy eye, crossed eyes, or any other eye condition that affects your focus, depth perception, or normal 3D vision
You did not pass a specific 3D vision test called the Titmus stereotest butterfly test (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905387359268

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07250672

Sponsor: Abant Izzet Baysal University

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: +905387359268

More information: https://clinicaltrials.gov/study/NCT07250672

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to take part in the study voluntarily
You have been diagnosed with Parkinson's disease by a neurologist
You are currently taking medication to treat your Parkinson's disease
Your Parkinson's symptoms are at a mild to moderate level (rated stage 3 or below on a standard scale used by doctors)
You are able to walk on your own without assistance

Who may not be able to join:

You have been diagnosed with another neurological condition in addition to Parkinson's disease
Your Parkinson's medication dose has been changed in the last month
You scored highly on a questionnaire that measures discomfort caused by simulators or virtual environments (confirm with trial site)
You have a lazy eye, crossed eyes, or any other eye condition that affects your focus, depth perception, or normal 3D vision
You did not pass a specific 3D vision test called the Titmus stereotest butterfly test (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Abant Izzet Baysal University

Registry

ClinicalTrials.gov

Start date

15 December 2025

Est. completion

15 July 2027

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Spontaneous Movement Rate (SMR

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov